MedCheckr ABPI Mobile App - ABPI Compliance Checker for iPhone | PharmaTools.AI
ABPI Code 2024

ABPI compliance in your pocket

Check promotional claims against the ABPI code instantly. Your essential companion for pharmaceutical compliance, now on iPhone.

Everything you need for ABPI compliance

Instant Analysis

Get compliance results in seconds with our advanced AI-powered analysis engine

Precise Guidance

Receive specific clause references and detailed explanations for every finding

Smart Suggestions

Get AI-generated compliant alternatives for any flagged promotional claims

Simple as 1-2-3

1

Enter Your Claim

Type, scan or dictate your promotional claim into the app

2

Instant Analysis

Our AI checks compliance against the 2024 ABPI Code of Practice

3

Get Results

Receive detailed feedback with compliant alternatives and related PMCPA rulings

Loved by professionals

"

Having the tool return the exact section of the Code needed to show the client why they can't use those phrases could be extremely useful and time-saving.

Cathy Williams
Medical Writer, Cambridge
"

Brilliant tool! Easy to use, and love not only how it gives you the clauses that you may be contravening but also provides what you could do instead.

Vicky Thompson
Compliance Manager, Harrogate
"

One of the more useful AI tools for medical writing! The mobile app makes it so convenient to check claims on the go.

Catherine Meyer
Medical Writer, Zurich
"

This could be a very helpful tool and was easy to use. The interface looks great and works seamlessly on iPhone.

Carole Johnson
Regulatory Affairs, North Carolina

Ready to ensure compliance?

Join thousands of pharmaceutical professionals using MedCheckr ABPI

Download on the App Store

MedCheckr ABPI provides AI-generated interpretations based on the ABPI Code of Practice 2024. Outputs are intended as decision-support only and do not represent the views of the PMCPA or any regulatory authority. The ABPI code is subject to periodic updates; users are responsible for ensuring their materials align with the latest guidance. No affiliation or endorsement is claimed or implied.